Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Alector, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ALEC
Nasdaq
2836
www.alector.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Alector, Inc.
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
- Sep 19th, 2024 12:00 pm
Alector (NASDAQ:ALEC) investors are sitting on a loss of 77% if they invested three years ago
- Sep 19th, 2024 11:04 am
Ascendis Pharma (ASND) Moves 17.1% Higher: Will This Strength Last?
- Sep 17th, 2024 1:02 pm
Alector to Participate in Upcoming Healthcare Conferences
- Aug 29th, 2024 11:00 am
Director Richard Scheller Sells 44,250 Shares of Alector Inc (ALEC)
- Aug 23rd, 2024 11:19 pm
Alector Second Quarter 2024 Earnings: Beats Expectations
- Aug 9th, 2024 10:52 am
Alector (ALEC) Reports Q2 Loss, Lags Revenue Estimates
- Aug 7th, 2024 10:15 pm
Alector: Q2 Earnings Snapshot
- Aug 7th, 2024 9:11 pm
Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
- Aug 7th, 2024 8:05 pm
Alector to Host Mid-Year Earnings Conference Call
- Jul 31st, 2024 8:05 pm
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
- Jul 28th, 2024 12:05 pm
Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024
- Jul 23rd, 2024 11:00 am
Why Did Analysts Give Alector, Inc. (ALEC) a Moderate Buy Rating?
- Jun 30th, 2024 12:43 am
Prothena (PRTA) Moves 9.3% Higher: Will This Strength Last?
- Jun 24th, 2024 12:48 pm
Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
- Jun 20th, 2024 11:00 am
Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform
- Jun 10th, 2024 11:00 am
Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Jun 3rd, 2024 11:00 am
Here's Why We're Watching Alector's (NASDAQ:ALEC) Cash Burn Situation
- May 11th, 2024 2:03 pm
Alector (ALEC) Reports Q1 Loss, Tops Revenue Estimates
- May 8th, 2024 10:25 pm
Alector Reports First Quarter 2024 Financial Results and Provides Business Update
- May 8th, 2024 8:05 pm
Scroll